related documents
- A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer Conferences
- A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer Conferences
- A phase II study of patupilone in patients (pts) with metastatic castration-resistant prostate cancer (CRPC) who have progressed after docetaxel Conferences
- A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma Conferences
- A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium Conferences
- A phase II trial of voreloxin in women with platinum-resistant ovarian cancer Conferences
- A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer Conferences
- Case report of a 27-year-old male with DCIS Conferences
- Comparison of randomized phase II studies (RP2s) and subsequent randomized controlled studies (RCTs) using identical systemic therapies Conferences
- Cost-effectiveness of cetuximab for the first-line treatment of squamous cell carcinoma of the head and neck (SCCHN) in Canada Conferences
- Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study Conferences
- Differences in uptake of postoperative adjuvant chemotherapy for lung cancer: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study Conferences
- Economic guidelines for oncology products: Adaptation of the Canadian Agency for Drugs and Technologies in Health (CADTH) technology assessment guidance document Conferences
- Effect of geographic distance from a cancer centre on choice of systemic therapy in metastatic colorectal cancer Conferences
- Impact of positron emission tomography (PET) in stage III non-small cell lung cancer (NSCLC): A prospective randomized trial (PET START) Conferences
- Importance of stratification when measuring quality of care: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study Conferences
- Integration between primary care providers and the cancer system: Gaps and opportunities Conferences
- Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC) Conferences
- Mature results of a randomized phase II study of OGX-011 in combination with docetaxel/prednisone versus docetaxel/prednisone in patients with metastatic castration-resistant prostate cancer Conferences
- OGX-427, a 2 ' methoxyethyl antisense oligonucleotide (ASO), against HSP27: Results of a first-in-human trial Conferences
- Phase I dose escalation trial of sorafenib as a single agent for adults with relapsed and refractory acute leukemias Conferences
- Phase I study of intravenous decitabine in combination with oral vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas (NHL) Conferences
- Phase II study of AVR118 in the management of cancer related anorexia/cachexia Conferences
- Phase Ib dose finding trial of intravenous panobinostat with docetaxel in patients with castration-resistant prostate cancer (CRPC) Conferences
- Predictors of recurrent thrombosis and anticoagulant-related bleeding in patients with cancer Conferences
- Primary tumor and patient characteristics in breast cancer as predictors of adjuvant chemotherapy regimen: A regression model Conferences
- Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer Conferences
- The McGill Cancer Nutrition and Rehabilitation Program Conferences
- The management of dysphagia in esophageal cancer patients undergoing neoadjuvant chemotherapy: Is invasive tube feeding required? Conferences
- Treatment and outcome of patients with brain metastases from non-small cell lung cancer (NSCLC) Conferences
- Trends in the application of dynamic allocation methods in multiarm cancer clinical trials Conferences
- Two-years biochemical failure-free survival following high intensity focused ultrasound (HIFU) for localized prostate cancer: Prospective single center study of 196 patients Conferences
- Willingness of breast cancer survivors to participate in a randomized controlled trial (RCT) of digital mammography with or without magnetic resonance imaging (MRI) as breast cancer (BC) surveillance: A feasiblity study Conferences